Badar M. Mian, MD
Robotic radical nephrectomy sees steady increase in use
"In the end, it is up to the surgeons who wish to continue to perform these robotic procedure to demonstrate their cost-effectiveness," writes Badar M. Mian, MD.
Immediate post-TURBT mitomycin instillation reduces recurrence risk
Mitomycin C instillation within 24 hours after transurethral resection of non-muscle invasive bladder cancer significantly reduces the risk of recurrence and delays the time to recurrence.
Robotic vs. open RP: Better EF recovery seen with robot
Robot-assisted radical prostatectomy was associated with earlier and increased rate of recovery of erectile function when compared to radical retropubic prostatectomy and a slightly higher but acceptable rate of positive surgical margins, according to a study published online in European Urology (Sept. 4, 2017).
ADT plus salvage RT lowers PCa metastases, raises survival
A recent review of two phase III randomized controlled trials demonstrated that addition of androgen deprivation therapy to salvage pelvic radiation therapy for prostate cancer recurrence after radical prostatectomy reduces the risk of metastases and improves overall survival.
Most robotic RPs performed at low-volume hospitals
In a recent study, increasing hospital volume was significantly associated with improved perioperative outcomes.
Vibration therapy promising for treating stone fragments
Badar M. Mian, MD, discusses a recent study about the use of external physical vibration lithecbole for treating residual stones after retrograde intrarenal surgery.
Updated prostate Bx paper outlines preventive strategies
“Journal Article of the Month” is a new Urology Times section in which Badar M. Mian, MD, in which Badar M. Mian, MD (left), offers perspective on noteworthy research in the peer-reviewed literature. Dr. Mian is associate professor of surgery in the division of urology at Albany Medical College, Albany, NY.
Testis Ca care deviates from guidelines in 30% of patients
Nearly one-third of men with testicular cancer undergo diagnostic or therapeutic interventions that are at odds with guidelines from the National Comprehensive Cancer Network (NCCN), according a study published in the Journal of Urology (2017; 197:684-9).
Major decline in prostate Bx rates follows PSA publications
“It is clear that in order to reduce the morbidity of PSA screening and early detection of prostate cancer, more needs to be done,” writes Badar M. Mian, MD.

Poll